Hospital Pharmacy - June 2017 - 415

415

Dickerson et al
2.

Nicolo et al. Clinical outcomes related to protein
delivery in a critically ill population: a multicenter,
multinational observation study.6

The intent of this retrospective observational study was to
evaluate the impact of prescribed protein delivery on mortality and time to discharge alive using previously collected data
from the International Nutrition Survey 2013. The data sample included patients who were in the ICU for at least 4 days
(n = 2828) and a subsample of patients who were in the ICU
for at least 12 days (n = 1584). About two-thirds of patients
were medical ICU patients. Mean protein intake was 51 and
57 g/d for each group, respectively (61% and 67% of prescribed target intake of 1.2 g/kg/d). Caloric intake was 1100
and 1200 kcal/d (64% and 71% of prescribed target intake of
24 kcal/kg/d) for each group. The investigators stratified
patients based on a protein or energy intake of ≥80% of prescribed protein intake. Achieving a protein intake of ≥80% of
prescribed was associated with reduced mortality for each
duration of ICU stay group (25% vs 33% and 20% vs 27%;
OR of 0.68 and 0.60 for the ≥4 and ≥12 day groups, respectively) and a shorter time to discharge alive with higher protein intake in the 12-day subgroup. However, achievement of
≥80% of goal energy intake was not associated with improved
outcomes. The investigators concluded that achieving a
higher protein intake may be important for survival and
shorter time to discharge alive in ICU patients and that efforts
to achieve prescribed protein intake should be maximized.
These data support other recent studies that have associated improved clinical outcomes with increased protein
intake.28,29 Together, these studies infer the importance of
providing adequate protein intake and may offer an explanation as to why other recent nutritional intervention trials,
which focused on caloric intake while giving "inadequate
amounts" of protein, failed in terms of improving clinical
outcomes. However, the observational nature of this investigation6 and that of others limit the interpretation. In particular, the etiology for why patients only received 60% of what
was prescribed was elusive. Trials to identify the amount of
protein required to improve clinical outcomes for critically
ill patients are warranted. These future randomized controlled trials will need to be conducted in homogeneous ICU
patient populations as not all ICU patients are the same with
some exhibiting more catabolism than others. Currently, clinician experts recommend a protein intake of at least 1.2 g/
kg/d with doses up to 2 to 2.5 g/kg/d depending on the
patient's severity of catabolism.30 These emerging data indicate the importance of achieving adequate protein intake in
critically ill patients.
3.

Petros et al. Hypocaloric vs normocaloric nutrition in
critically ill patients: a prospective randomized pilot
trial.8

normocaloric regimen over the first 7 days in the ICU.
Patients anticipated to require artificial nutrition support for
at least 72 hours were assigned to receive either a normocaloric nutrition regimen (equivalent to daily energy expenditure; n = 54) or a hypocaloric nutrition regimen (50% of daily
energy expenditure; n = 46). Energy requirements were
determined via indirect calorimetry (IC) or by using the
Ireton-Jones equation31 if IC was unavailable. Enteral nutrition was preferentially used, although patients could receive
PN or supplemental PN with EN.
The study groups were similar with respect to age, body
mass index (BMI), and Acute Physiology and Chronic Health
Evaluation II (APACHE II) score, although more patients in
the hypocaloric arm had diabetes mellitus and chronic respiratory disease. Patients who were malnourished (BMI <18.5
kg/m2), >80 years old, or those receiving immunosuppressive therapy were excluded. A higher incidence of nosocomial infections was observed in the hypocaloric group
(26.1% vs 11.1%, P = .046) without any differences in ICU,
hospital, or 28-day mortality. Patients in the hypocaloric
group had lower insulin requirements (P < .05), but experienced more episodes of hypoglycemia (P = .03). Diarrhea
was more frequent in the normocaloric group on days 4 and
5 (P = .036). The authors concluded hypocaloric feeding
over the first 7 days of ICU stay was associated with more
nosocomial infections but improved glycemic control and
less gastrointestinal intolerance.
The findings of this study should be interpreted cautiously.
Patients with higher nutrition risk (eg, preexisting malnourishment, preexisting medical conditions, elderly patients), who
may benefit more from nutrition therapy, were poorly represented or excluded from study enrollment. The intent of this
study was to compare full feeding with hypocaloric feeding,
but the normocaloric group received only 75.5% of the prescribed regimen. Many clinicians would consider both groups
to have been permissively underfed. It is likely that neither
group received recommended amounts of protein (1.2-2 g/
kg/d) according to the Society of Critical Care Medicine
(SCCM)-ASPEN guidelines.16 Recent data suggest that protein provision may be more significant in improving outcomes
than caloric adequacy in critically ill patients6,16,29,32 which
may have confounded the results of this study. Therefore, it is
difficult to extrapolate the results of this study to more diverse
ICU populations. Other studies evaluating permissive and trophic feeding strategies have demonstrated lack of outcome
benefit or harm with full feeding,33,34 but included a narrower
patient population, with few patients more likely to experience
a higher nutrition risk. While it appears hypocaloric, low protein feeding may be better tolerated in this patient subset, it
may be associated with increased risk of nosocomial infections and should be cautiously utilized in broader ICU populations until more evidence is available.
4.

The objective of this single-center pilot trial was to compare the impact of a hypocaloric feeding regimen with a

Al-Dorzi et al. Lower versus higher dose of enteral
caloric intake in adult critically ill patients: a systematic review and meta-analysis.1



Table of Contents for the Digital Edition of Hospital Pharmacy - June 2017

Formal Leadership: Thrilling (and Scary) Like a Roller Coaster Ride
ISMP Medication Error Report Analysis
Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases
Formulary Drug Reviews: Plecanatide
Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Prophylaxis: A Review of a Drug Class or Therapeutic Class in a Late Stage of Clinical Development
Highly Probable Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Lenalidomide
Significant Published Articles for Pharmacy Nutrition Support Practice in 2016
Financial Effect of a Drug Distribution Model Change on a Health System
Limited Influence of Excipients in Extemporaneous Compounded Suspensions
Improved Outcomes and Cost Savings Associated With Pharmacist Presence in the Emergency Department
Patients Given Take Home Medications Instead of Paper Prescriptions Are More Likely to Return to Emergency Department
Hospital Pharmacy - June 2017 - 381
Hospital Pharmacy - June 2017 - 382
Hospital Pharmacy - June 2017 - 383
Hospital Pharmacy - June 2017 - 384
Hospital Pharmacy - June 2017 - 385
Hospital Pharmacy - June 2017 - 386
Hospital Pharmacy - June 2017 - 387
Hospital Pharmacy - June 2017 - Formal Leadership: Thrilling (and Scary) Like a Roller Coaster Ride
Hospital Pharmacy - June 2017 - 389
Hospital Pharmacy - June 2017 - ISMP Medication Error Report Analysis
Hospital Pharmacy - June 2017 - 391
Hospital Pharmacy - June 2017 - 392
Hospital Pharmacy - June 2017 - 393
Hospital Pharmacy - June 2017 - Cancer Chemotherapy Update: Bevacizumab, Etoposide, and Cisplatin Regimen for Refractory Brain Metastases
Hospital Pharmacy - June 2017 - 395
Hospital Pharmacy - June 2017 - 396
Hospital Pharmacy - June 2017 - 397
Hospital Pharmacy - June 2017 - 398
Hospital Pharmacy - June 2017 - 399
Hospital Pharmacy - June 2017 - Formulary Drug Reviews: Plecanatide
Hospital Pharmacy - June 2017 - 401
Hospital Pharmacy - June 2017 - 402
Hospital Pharmacy - June 2017 - 403
Hospital Pharmacy - June 2017 - 404
Hospital Pharmacy - June 2017 - 405
Hospital Pharmacy - June 2017 - Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Prophylaxis: A Review of a Drug Class or Therapeutic Class in a Late Stage of Clinical Development
Hospital Pharmacy - June 2017 - 407
Hospital Pharmacy - June 2017 - Highly Probable Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Lenalidomide
Hospital Pharmacy - June 2017 - 409
Hospital Pharmacy - June 2017 - 410
Hospital Pharmacy - June 2017 - 411
Hospital Pharmacy - June 2017 - Significant Published Articles for Pharmacy Nutrition Support Practice in 2016
Hospital Pharmacy - June 2017 - 413
Hospital Pharmacy - June 2017 - 414
Hospital Pharmacy - June 2017 - 415
Hospital Pharmacy - June 2017 - 416
Hospital Pharmacy - June 2017 - 417
Hospital Pharmacy - June 2017 - 418
Hospital Pharmacy - June 2017 - 419
Hospital Pharmacy - June 2017 - 420
Hospital Pharmacy - June 2017 - 421
Hospital Pharmacy - June 2017 - Financial Effect of a Drug Distribution Model Change on a Health System
Hospital Pharmacy - June 2017 - 423
Hospital Pharmacy - June 2017 - 424
Hospital Pharmacy - June 2017 - 425
Hospital Pharmacy - June 2017 - 426
Hospital Pharmacy - June 2017 - 427
Hospital Pharmacy - June 2017 - Limited Influence of Excipients in Extemporaneous Compounded Suspensions
Hospital Pharmacy - June 2017 - 429
Hospital Pharmacy - June 2017 - 430
Hospital Pharmacy - June 2017 - 431
Hospital Pharmacy - June 2017 - 432
Hospital Pharmacy - June 2017 - Improved Outcomes and Cost Savings Associated With Pharmacist Presence in the Emergency Department
Hospital Pharmacy - June 2017 - 434
Hospital Pharmacy - June 2017 - 435
Hospital Pharmacy - June 2017 - 436
Hospital Pharmacy - June 2017 - 437
Hospital Pharmacy - June 2017 - Patients Given Take Home Medications Instead of Paper Prescriptions Are More Likely to Return to Emergency Department
Hospital Pharmacy - June 2017 - 439
Hospital Pharmacy - June 2017 - 440
Hospital Pharmacy - June 2017 - 441
Hospital Pharmacy - June 2017 - 442
Hospital Pharmacy - June 2017 - 443
Hospital Pharmacy - June 2017 - 444
Hospital Pharmacy - June 2017 - 445
Hospital Pharmacy - June 2017 - 446
Hospital Pharmacy - June 2017 - 447
Hospital Pharmacy - June 2017 - 448
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com